Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
暂无分享,去创建一个
Wang Li | Pi Guo | Peihong Wu | Jingjun Huang | Tao Pan | Chaofeng Li | Peihong Wu | Jingjun Huang | Qifeng Chen | Tao Huang | Lujun Shen | Wang Li | Lujun Shen | Lewei Yang | Qi Zeng | Boyang Chang | Nan Wu | Lewei Yang | Qifeng Chen | Tao Huang | B. Chang | Qianwen Zeng | Chaofeng Li | T. Pan | Pi Guo | Nan Wu
[1] Yuanxi Li,et al. Updating Markov models to integrate cross-sectional and longitudinal studies , 2017, Artif. Intell. Medicine.
[2] Milos Hauskrecht,et al. A Temporal Abstraction Framework for Classifying Clinical Temporal Data , 2009, AMIA.
[3] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[4] Ma Li,et al. CURE-SMOTE algorithm and hybrid algorithm for feature selection and parameter optimization based on random forests , 2017, BMC Bioinformatics.
[5] R. Lencioni,et al. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? , 2010, The oncologist.
[6] M. Kudo,et al. Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study , 2016, Oncotarget.
[7] Seungjin Choi,et al. Inference of dynamic networks using time-course data , 2014, Briefings Bioinform..
[8] V. Mazzaferro,et al. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .
[9] H. Heinzl,et al. The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma , 2013, Hepatology.
[10] Riccardo Lencioni,et al. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.
[11] J. Bruix,et al. Treatment of intermediate-stage hepatocellular carcinoma , 2014, Nature Reviews Clinical Oncology.
[12] J J Deeks,et al. Systematic reviews of published evidence: miracles or minefields? , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[14] M. Dumont,et al. European Association for the Study of the Liver , 1971 .
[15] Dimitrios I. Fotiadis,et al. Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.
[16] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[17] Riccardo Lencioni,et al. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.
[18] Sameem Abdul Kareem,et al. Oral cancer prognosis based on clinicopathologic and genomic markers using a hybrid of feature selection and machine learning methods , 2013, BMC Bioinformatics.
[19] Cécile Proust-Lima,et al. Quantifying and comparing dynamic predictive accuracy of joint models for longitudinal marker and time‐to‐event in presence of censoring and competing risks , 2015, Biometrics.
[20] M. Carvello,et al. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy? , 2013, World journal of gastroenterology.
[21] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[22] A review , 2019 .
[23] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[24] Haiyong Wang,et al. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy , 2013, World Journal of Surgical Oncology.
[25] Gaëtan MacGrogan,et al. Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer , 2010, BMC medical research methodology.
[26] P. Goldstraw. New TNM classification: achievements and hurdles. , 2013, Translational lung cancer research.
[27] Cécile Proust-Lima,et al. Joint latent class models for longitudinal and time-to-event data: A review , 2014, Statistical methods in medical research.
[28] H. Ye,et al. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection. , 2016, International journal of surgery.
[29] R. Xu,et al. Validation and ranking of seven staging systems of hepatocellular carcinoma , 2017, Oncology letters.